Kolovos, S., Kleiboer, A. & Cuijpers, P. Effect of psychotherapy for depression on quality of life: meta analysis. Br. J. Psychiatry 209, 460 468 (2016).
 Barney, L. J., Griffiths, K. M. & Banfield, M. A. Explicit and implicit information needs of people with depression: a qualitative investigation of problems reported on an online depression
support forum. BMC Psychiatry 11, 88 (2011).
 Papakostas, G. I. et al. Quality of life assessments in major depressive disorder: a review of the literature. Gen. Hosp. Psychiatry 26, 13 17 (2004).
 Broadhead, W. E., Blazer, D. G., George, L. K. & Tse, C. K. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA 264, 2524 2528 (1990).
 Fiorillo, A. et al. Family burden in major depression: a multicentric survey in 30 italian mental health centres. Eur. Psychiatry 26, 625 (2011).
 Saragoussi, D. et al. Long term follow up on health related quality of life in major depressive disorder: a 2 year European cohort study. Neuropsychiatr. Dis. Treat. 14, 1339 1350 (2018).
 IsHak, W. W. et al. Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity. Psychopharmacol. Bull. 48, 8–25 (2018).
 Kan, K. et al. Real World Treatment Costs and Care Utilization in Patients with Major Depressive Disorder With and Without Psychiatric Comorbidities in Specialist Mental Healthcare.
Pharmacoeconomics 39, 721 730 (2021).
 Jia, H. & Lubetkin, E. I. Incremental decreases in quality adjusted life years (QALY) associated with higher levels of depressive symptoms for U.S. Adults aged 65 years and older. Health
Qual. Life Outcomes 15, 9 (2017).
 Feldman, R. L., Dunner, D. L., Muller, J. S. & Stone, D. A. Medicare patient experience with vagus nerve stimulation for treatment resistant depression. J. Med. Econ. 16, 62 74 (2013).
 Heerlein, K. et al. Real world evidence from a European cohort study of patients with treatment resistant depression: Baseline patient characteristics. J. Affect. Disord. 283, 115 122 (2021).
 Kawada, T. Letter to Yang T, et al. Increased risk of adverse cardiovascular events by strict glycemic control after percutaneous coronary intervention in type 2 diabetes mellitus combined
with acute coronary syndrome. Curr Med Res Opin. 2021;37(9):1517 1528. Current medical research and opinion 1 3 (2022) doi:10.1080/03007995.2022.2061709.
 Madsen, K. B. et al. Cause specific life years lost in individuals with treatment resistant depression: A Danish nationwide register based cohort study. J. Affect. Disord. 280, 250 257 (2021).
 Ruggeri, M. et al. The costs of treatment resistant depression: evidence from a survey among Italian patients. Expert Rev. Pharmacoecon. Outcomes Res. 1–8 (2021) doi:10.1080/14737167.2021.1954507.